Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Recent patents disclose novel agents for the treatment of endocrine-related disorders

Nov. 25, 2005

Shire submits BLA for Elaprase for Hunter's syndrome

Nov. 25, 2005

Obestatin: a newly identified hormone that suppresses appetite

Nov. 25, 2005

Recent patents report new therapeutic agents for metabolic disorders

Nov. 23, 2005

PEG-Uricase lowers plasma urate levels, may resolve tophi in gout patients

Nov. 23, 2005

SERMs described in Council of Scientific and Industrial Research patent

Nov. 21, 2005

SMP-534 effective in treating diabetic nephropathy in db/db mice

Nov. 21, 2005

Actelion and UCB replace license agreement for Zavesca

Nov. 21, 2005

FG-4592: A selective and potent oral erythropoietic agent from FibroGen

Nov. 21, 2005

Recent patents disclose novel agents for the treatment of endocrine-related disorders

Nov. 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...